{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
HealthStream, Inc.
HealthStream, Inc. Hits New 52-Week Low at $24.07
HealthStream, Inc. has reached a new 52-week low, reflecting a year-to-date decline while the S&P 500 has gained. The company, with a market cap of approximately USD 833 million, shows modest growth in net sales and operating profit, but has underperformed against broader market indices over the past three years.
Is HealthStream, Inc. overvalued or undervalued?
As of October 31, 2025, HealthStream, Inc. is fairly valued with a P/E ratio of 46, a Price to Book Value of 2.40, and an EV to EBITDA of 12.29, indicating a more attractive valuation compared to peers like Pagaya Technologies and Couchbase, despite not being undervalued.
HealthStream, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations
HealthStream, Inc. has recently adjusted its valuation, with a P/E ratio of 46 and a price-to-book value of 2.40. Key metrics include an EV to EBIT ratio of 37.92 and a ROCE of 8.01%. Despite a year-to-date return of -22.64%, the company shows a favorable position compared to peers.
Is HealthStream, Inc. overvalued or undervalued?
As of October 31, 2025, HealthStream, Inc. is fairly valued with a P/E ratio of 46, an EV to EBITDA of 12.29, and a PEG ratio of 6.67, indicating stability compared to peers despite a year-to-date return of -22.64%.
Is HealthStream, Inc. overvalued or undervalued?
As of October 31, 2025, HealthStream, Inc. is fairly valued with a P/E ratio of 46, but its stock has underperformed the S&P 500 with a year-to-date return of -22.64%.
HealthStream, Inc. Stock Plummets to New 52-Week Low of $24.37
HealthStream, Inc. has reached a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, with a market cap of USD 833 million, shows a high P/E ratio and has not paid dividends. Despite a slight profit increase, long-term growth remains a challenge.
HealthStream, Inc. Stock Plummets to New 52-Week Low of $24.39
HealthStream, Inc. has reached a new 52-week low, reflecting an 11.89% decline in its stock performance over the past year. The company, with a market capitalization of USD 833 million, has a high P/E ratio and has not paid dividends, indicating a conservative financial strategy.
Is HealthStream, Inc. overvalued or undervalued?
As of October 17, 2025, HealthStream, Inc. is considered fairly valued and potentially overvalued with high ratios, underperforming the S&P 500 year-to-date by -16.54% compared to its 13.30% return.
HealthStream, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics
HealthStream, Inc. has recently adjusted its valuation, with a P/E ratio of 46 and a price-to-book value of 2.40. The company has shown mixed performance, with a weekly return of 3.67%, but declines over one month and year-to-date. Comparisons with peers reveal notable valuation disparities.
Is HealthStream, Inc. overvalued or undervalued?
As of October 17, 2025, HealthStream, Inc. is considered overvalued with a P/E ratio of 46 compared to the peer average of 40.95, and despite a recent short-term outperformance, its long-term returns have lagged behind the S&P 500, indicating a shift in its valuation from very attractive to fair.
Is HealthStream, Inc. overvalued or undervalued?
As of October 17, 2025, HealthStream, Inc. is considered fairly valued but overvalued based on its high P/E ratio of 46 and poor performance compared to the S&P 500, with a YTD return of -16.54% versus the index's 13.30%.
HealthStream, Inc. Hits New 52-Week Low at $25.00
HealthStream, Inc. has reached a new 52-week low, reflecting a notable decline in its performance over the past year. The company, with a market capitalization of USD 833 million, shows a premium valuation with a P/E ratio of 46.00 and modest growth in net sales and operating profit.
HealthStream, Inc. Hits New 52-Week Low at $25.20
HealthStream, Inc. has reached a new 52-week low, reflecting a notable decline in its performance over the past year. The company, with a market capitalization of USD 833 million, exhibits a high P/E ratio and modest growth in net sales and operating profit, alongside significant institutional interest.
HealthStream, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges
HealthStream, Inc. has recently adjusted its valuation, with a P/E ratio of 46 and a price-to-book value of 2.40. The company has faced performance challenges, showing a year-to-date return of -13.96%. Comparatively, its valuation metrics differ from peers like Pagaya Technologies and Couchbase, illustrating the competitive software sector landscape.
Is HealthStream, Inc. technically bullish or bearish?
As of August 21, 2025, HealthStream, Inc. has shifted to a mildly bearish trend with mixed technical signals, underperforming the S&P 500 over the past year and year-to-date, but showing stronger returns over the 3-year and 5-year periods.
Is HealthStream, Inc. overvalued or undervalued?
As of September 10, 2025, HealthStream, Inc. is fairly valued with a P/E ratio of 46 and has underperformed the S&P 500 year-to-date with a return of -8.27%, although it has a five-year return of 44.69%, indicating potential for future improvement.
Is HealthStream, Inc. overvalued or undervalued?
As of May 23, 2025, HealthStream, Inc. is considered overvalued with a valuation grade of expensive, highlighted by a high P/E ratio of 46 and a lagging performance compared to the S&P 500.
Is HealthStream, Inc. technically bullish or bearish?
As of June 18, 2025, HealthStream, Inc. is in a bearish trend with moderate strength, indicated by a bearish MACD, moving averages, and mixed signals from other indicators like the KST and RSI.
Who are in the management team of HealthStream, Inc.?
As of March 2022, the management team of HealthStream, Inc. includes Chairman and CEO Mr. Robert Frist, Lead Independent Director Mr. Thompson Dent, and independent directors Mr. Frank Gordon, Dr. C. Martin Harris, Mr. Jeffrey McLaren, and Ms. Linda Rebrovick.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
